OptiBiotix Health Plc (FRA:OB3)

Germany · Delayed Price · Currency is EUR

0.0705

+0.0025 (3.68%)

At close: Jun 26, 2026

-32.21% (1Y)

Market Cap	7.60M -46.1%
Revenue (ttm)	1.34M +34.0%
Net Income	-4.46M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0705
Previous Close	0.0680
Day's Range	0.0705 - 0.0705
52-Week Range	0.0380 - 0.1440
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 30, 2026

About OptiBiotix Health

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its first-generation products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunge... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2006

Employees 9

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol OB3

Financial Performance

In 2025, OptiBiotix Health's revenue was 1.17 million, an increase of 34.02% compared to the previous year's 870,000. Losses were -3.89 million, 115.5% more than in 2024.

Financial numbers in GBP Financial Statements